Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)

Anthony V. Moorman(Newcastle University), Christine J. Harrison(Newcastle University), Ajay Vora(Great Ormond Street Hospital), Hazel M. Robinson(Blood Cancer UK), Sally E. Kinsey(St James's University Hospital), Christopher Mitchell(John Radcliffe Hospital), Susan Richards(MRC Clinical Trials Unit at UCL), Tim Eden(University of Manchester), Brenda Gibson(Royal Hospital for Children), Jonathan C. Strefford(University of Southampton)
Blood
November 9, 2006
10.1182/blood-2006-08-040436
Cited by 221

Related Papers

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
|Blood|2006|843
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
|Blood|2007|782
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
|Blood|2006|746
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
|Blood|2009|494